Patent intelligence · US
US 7346387
Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents
Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents
Patent details — US 7346387
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 18, 2008
- Expiration
- Mar 13, 2028
- Applicant
- Provectus Devicetech, Inc.
- Claims
- 19
- CPC classes
- A61K, A61K41/008, A61K49/0017, A61K49/0039
Quick answer
US 7346387 (Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents) is held by Provectus Devicetech, Inc.. Status: granted. Granted Mar 18, 2008. Expires Mar 13, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Provectus Devicetech, Inc.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K41/008, A61K49/0017, A61K49/0039, A61K49/0043
More from Provectus Devicetech, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12377068
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 12133840
Halogenated xanthene composition and method for treating hematologic cancers
granted -
US 12064507
Composition and method for oral treatment of leukemia
granted -
US 11974980
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 11975106
Uses of halogenated xanthenes in oncology and virology
granted -
US 11938182
Halogenated xanthenes as vaccine adjuvants
granted -
US 11426379
Combination of local and systemic therapies for enhanced treatment of dermatologic conditions
granted -
US 11419844
Halogenated xanthene composition and method for treating hematologic cancers
granted
Frequently asked questions
What is US patent 7346387?
US 7346387 (Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents) is held by Provectus Devicetech, Inc.. Status: granted. Granted Mar 18, 2008. Expires Mar 13, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7346387?
Provectus Devicetech, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 29 pharmaceutical patents for this assignee.
When does US 7346387 expire?
Our index shows an expiration date of Mar 13, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.